MTOR and metabolic syndrome: Of note, Astragaloside IV, a natural saponin extracted from AM, was unfolded to attenuate liver injury in type 2 diabetes by regulating the AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR)/autophagy pathway, which could alleviate insulin resistance and dyslipidemia [13].